Display options
Cite
Ross EL, Jorgensen J, DeWitt PE, et al. Comparison of 3 body size descriptors in critically ill obese children and adolescents: implications for medication dosing. J Pediatr Pharmacol Ther. 2014;19(2):103-10doi: 10.5863/1551-6776-19.2.103.
Ross, E. L., Jorgensen, J., DeWitt, P. E., Okada, C., Porter, R., Haemer, M., & Reiter, P. D. (2014). Comparison of 3 body size descriptors in critically ill obese children and adolescents: implications for medication dosing. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 19(2), 103-10. https://doi.org/10.5863/1551-6776-19.2.103
Ross, Emma L, et al. "Comparison of 3 body size descriptors in critically ill obese children and adolescents: implications for medication dosing." The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG vol. 19,2 (2014): 103-10. doi: https://doi.org/10.5863/1551-6776-19.2.103
Ross EL, Jorgensen J, DeWitt PE, Okada C, Porter R, Haemer M, Reiter PD. Comparison of 3 body size descriptors in critically ill obese children and adolescents: implications for medication dosing. J Pediatr Pharmacol Ther. 2014 Apr;19(2):103-10. doi: 10.5863/1551-6776-19.2.103. PMID: 25024670; PMCID: PMC4093662.
Copy Download .nbib Format: NLM
Share it on

J Pediatr Pharmacol Ther. 2014 Apr;19(2):103-10. doi: 10.5863/1551-6776-19.2.103.

Comparison of 3 body size descriptors in critically ill obese children and adolescents: implications for medication dosing.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

Emma L Ross, Jennifer Jorgensen, Peter E DeWitt, Carol Okada, Renee Porter, Matthew Haemer, Pamela D Reiter

Affiliations

  1. Department of Clinical Pharmacy, Children's Hospital Colorado, Aurora, Colorado.
  2. Colorado School of Public Health, Biostatistics and Informatics, Colorado Biostatistics Consortium, Research Consulting Lab, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  3. Pediatric Intensive Care Unit, Section of Critical Care Medicine.
  4. Department of Pediatrics, Section of Nutrition Children's Hospital Colorado, Aurora, Colorado.

PMID: 25024670 PMCID: PMC4093662 DOI: 10.5863/1551-6776-19.2.103

Abstract

OBJECTIVE: To compare 3 methods of weight determination for medication dose calculations in obese children and to discuss feasibility for use in routine care.

METHODS: This was a patient safety and quality improvement study evaluating patients (2-19 years old) admitted to the pediatric intensive care unit during a 13-month period (July 2010-July 2011). Patients identified as obese (≥95th percentile body mass index [BMI] for age), including severely obese (≥99th percentile BMI for age), were included in the weight method comparison portion of this study. Lean body mass estimations, using equations derived by the Peters and Foster methods, were compared to ideal body weight estimates by using the BMI method. Absolute differences between values generated by the 3 methods, intraclass correlation (ICC), and Bland-Altman plots were calculated.

RESULTS: A total of 1369 patients met initial criteria; 176 met criteria for the dosing weight comparison (age ± SD = 9.28 ± 5 years; actual weight ± SD = 55.5 ± 33.9 kg; 46% female). Sixty were severely obese and 116 were obese. Mean ICC between methods was 0.968 (95% Confidence interval (CI): 0.959, 0.975). The Peters method estimated higher weights than the Foster or BMI method. Bland-Altman plots illustrated good agreement between methods in children with weight below 50 kg, but decreased agreement above 50 kg, which was influenced by sex.

CONCLUSIONS: All methods demonstrated strong correlation and acceptable agreement in children below 50 kg. Systematic biases were identified in children above 50 kg where variance was higher. The BMI method was least complex to calculate and the most feasible method for daily use.

Keywords: body mass index; ideal body weight; lean body mass; obesity; pediatric

References

  1. Arch Dis Child Educ Pract Ed. 2010 Aug;95(4):112-7 - PubMed
  2. Br J Anaesth. 2011 May;106(5):719-23 - PubMed
  3. Am J Clin Nutr. 2001 Apr;73(4):687-702 - PubMed
  4. Pharmacoepidemiol Drug Saf. 2013 Sep;22(9):970-6 - PubMed
  5. Int J Obes Relat Metab Disord. 1998 May;22(5):461-9 - PubMed
  6. J Clin Endocrinol Metab. 2001 Sep;86(9):4059-60 - PubMed
  7. Nutr Clin Pract. 2007 Apr;22(2):240-5 - PubMed
  8. J Bone Miner Res. 1998 Oct;13(10):1613-8 - PubMed
  9. Pediatrics. 2007 Dec;120 Suppl 4:S164-92 - PubMed
  10. Obesity (Silver Spring). 2008 Feb;16(2):457-62 - PubMed
  11. Ann Pharmacother. 2000 Sep;34(9):1066-9 - PubMed
  12. Br J Clin Pharmacol. 2004 Aug;58(2):119-33 - PubMed
  13. J Pediatr Pharmacol Ther. 2010 Apr;15(2):94-109 - PubMed
  14. Ann Hum Biol. 2012 May;39(3):171-82 - PubMed
  15. Arch Dis Child. 2006 Jul;91(7):612-7 - PubMed
  16. Am J Physiol. 1984 Oct;247(4 Pt 2):F632-6 - PubMed
  17. Int J Obes (Lond). 2005 Jan;29(1):1-8 - PubMed
  18. Clin Pharmacokinet. 2012 May 1;51(5):319-30 - PubMed
  19. Am J Clin Nutr. 1999 Jul;70(1):157S-162S - PubMed
  20. Am J Hosp Pharm. 1983 Jun;40(6):1016-9 - PubMed
  21. Am J Clin Nutr. 2002 Dec;76(6):1416-21 - PubMed

Publication Types

Grant support